Gemcitabine and Docetaxel Therapy in High-risk BCG-naive Patients With Non-muscle Invasive Bladder Cancer
Clinical trial NCT05671900 · UNKNOWN
Trial details
- NCT number
- NCT05671900
- Sponsor
- Clinical Hospital Centre Zagreb
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-01
- Primary completion
- 2024-06-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.